These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15238598)

  • 1. Fractionating heparins and their clinical trial data--something for everyone.
    Das P; Moliterno DJ
    JAMA; 2004 Jul; 292(1):101-3. PubMed ID: 15238598
    [No Abstract]   [Full Text] [Related]  

  • 2. Enoxaparin vs unfractionated heparin in acute coronary syndrome.
    Kanna B; Sharma P
    JAMA; 2004 Oct; 292(16):1952; author reply 1953. PubMed ID: 15507577
    [No Abstract]   [Full Text] [Related]  

  • 3. Enoxaparin vs unfractionated heparin in acute coronary syndrome.
    Pedrini M; Hartig F; Pechlaner C
    JAMA; 2004 Oct; 292(16):1952; author reply 1952-3. PubMed ID: 15507578
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin in acute coronary disease--requiem for a heavyweight?
    Armstrong PW
    N Engl J Med; 1997 Aug; 337(7):492-4. PubMed ID: 9250854
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview.
    Petersen JL; Mahaffey KW; Hasselblad V; Antman EM; Cohen M; Goodman SG; Langer A; Blazing MA; Le-Moigne-Amrani A; de Lemos JA; Nessel CC; Harrington RA; Ferguson JJ; Braunwald E; Califf RM
    JAMA; 2004 Jul; 292(1):89-96. PubMed ID: 15238596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of unstable angina and myocardial infarction.
    Cohen M; Turpie AG
    Lancet; 2000 Sep; 356(9236):1193-4. PubMed ID: 11030322
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
    Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F
    N Engl J Med; 1997 Aug; 337(7):447-52. PubMed ID: 9250846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.
    Blazing MA; de Lemos JA; White HD; Fox KA; Verheugt FW; Ardissino D; DiBattiste PM; Palmisano J; Bilheimer DW; Snapinn SM; Ramsey KE; Gardner LH; Hasselblad V; Pfeffer MA; Lewis EF; Braunwald E; Califf RM;
    JAMA; 2004 Jul; 292(1):55-64. PubMed ID: 15238591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparins (enoxaparin) in the management of unstable angina: the TIMI studies. Thrombolysis in Myocardial Infarction.
    Gurfinkel E; Scirica BM
    Heart; 1999 Sep; 82 Suppl 1(Suppl 1):I15-7. PubMed ID: 10469673
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antithrombotic therapy of unstable angina pectoris].
    Lassila R
    Duodecim; 1998; 114(15):1441, 1443-4. PubMed ID: 11552230
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin, heparin, or both to treat unstable angina.
    N Engl J Med; 1989 Apr; 320(15):1014-5. PubMed ID: 2633752
    [No Abstract]   [Full Text] [Related]  

  • 12. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.
    Ferguson JJ; Califf RM; Antman EM; Cohen M; Grines CL; Goodman S; Kereiakes DJ; Langer A; Mahaffey KW; Nessel CC; Armstrong PW; Avezum A; Aylward P; Becker RC; Biasucci L; Borzak S; Col J; Frey MJ; Fry E; Gulba DC; Guneri S; Gurfinkel E; Harrington R; Hochman JS; Kleiman NS; Leon MB; Lopez-Sendon JL; Pepine CJ; Ruzyllo W; Steinhubl SR; Teirstein PS; Toro-Figueroa L; White H;
    JAMA; 2004 Jul; 292(1):45-54. PubMed ID: 15238590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE.
    Antman EM; Cohen M; McCabe C; Goodman SG; Murphy SA; Braunwald E;
    Eur Heart J; 2002 Feb; 23(4):308-14. PubMed ID: 11812067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).
    Huynh T; Theroux P; Snapinn S; Wan Y;
    Am Heart J; 2003 Oct; 146(4):668-73. PubMed ID: 14564321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moving beyond unfractionated heparin for acute coronary syndromes: Xeno's Paradox revisited.
    Ferguson JJ
    Eur Heart J; 2002 Feb; 23(4):264-8. PubMed ID: 11812059
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current developments in the treatment of unstable angina pectoris and acute myocardial infarct].
    Vlaicu R; Olinic N
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(2):117-28. PubMed ID: 2908073
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy.
    Cohen M; Stinnett SS; Weatherley BD; Gurfinkel EP; Fromell GJ; Goodman SG; Fox KA; Califf RM
    Am Heart J; 2000 Jun; 139(6):962-70. PubMed ID: 10827375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular weight heparins.
    Talley JD
    J Ark Med Soc; 1997 Apr; 93(11):555-6. PubMed ID: 9114648
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombolysis in unstable angina: will the beneficial effects of thrombolytic therapy in myocardial infarction apply to patients with unstable angina?
    Ambrose JA; Alexopoulos D
    J Am Coll Cardiol; 1989 Jun; 13(7):1666-71. PubMed ID: 2656826
    [No Abstract]   [Full Text] [Related]  

  • 20. The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes: the Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory Substudy.
    Goodman SG; Bozovich GE; Tan M; Dos Santos A; Gurfinkel EP; Cohen M; Langer A;
    Am Heart J; 2006 Apr; 151(4):791-7. PubMed ID: 16569535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.